Manzo Pharmaceuticals Inc. (MNZO)

[investor_61]

So Ken Manzo has MNZO and its shareholders buy the rights to a product, fund the development of that product, then claims trouble with the SEC. He then walks away with the company and the rights to the product but the debt stays with MNZO and its shareholders. Now Ken Manzo is selling the product and gets 100% of the profit. Makes sense. How is that protecting the shareholders? The proper course of action is a class action lawsuit against Ken Manzo and the SEC. This assumes there ever was an action being taken by the SEC against Ken Manzo and a resulting settlement. I wouldn't be surprised if it's all BS.